Bonk (BNKK) & The Competition Head to Head Survey

Bonk (NASDAQ:BNKK) is one of 347 publicly-traded companies in the “Financial Services” industry, but how does it contrast to its competitors? We will compare Bonk to similar companies based on the strength of its dividends, valuation, earnings, risk, analyst recommendations, institutional ownership and profitability.

Profitability

This table compares Bonk and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Bonk	-952.21%	-137.47%	-122.67%
Bonk Competitors	-405.65%	-19.44%	-6.49%

Analyst Ratings

This is a breakdown of current recommendations for Bonk and its competitors, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bonk	1	0	0	0	1.00
Bonk Competitors	1900	6784	11474	413	2.51

As a group, “Financial Services” companies have a potential upside of 4.19%. Given Bonk’s competitors stronger consensus rating and higher probable upside, analysts plainly believe Bonk has less favorable growth aspects than its competitors.

Insider & Institutional Ownership

12.6% of Bonk shares are held by institutional investors. Comparatively, 42.6% of shares of all “Financial Services” companies are held by institutional investors. 51.6% of Bonk shares are held by insiders. Comparatively, 21.5% of shares of all “Financial Services” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Valuation and Earnings

This table compares Bonk and its competitors revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Bonk	$2.12 million	-$68.19 million	-0.34
Bonk Competitors	$6.35 billion	$1.06 billion	11.47

Bonk’s competitors have higher revenue and earnings than Bonk. Bonk is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Volatility and Risk

Bonk has a beta of 1.98, suggesting that its share price is 98% more volatile than the S&P 500. Comparatively, Bonk’s competitors have a beta of 2.25, suggesting that their average share price is 125% more volatile than the S&P 500.

Summary

Bonk competitors beat Bonk on 12 of the 13 factors compared.

Bonk Company Profile

Safety Shot, Inc., a wellness and functional beverage company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women’s sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as Jupiter Wellness, Inc. and changed its name to Safety Shot, Inc. in September 2023. The company was incorporated in 2018 and is headquartered in Jupiter, Florida.